FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020508488> ?p ?o ?g. }

• W2020508488 endingPage "3725" @default.
• W2020508488 startingPage "3716" @default.
• W2020508488 abstract "Leishmania infantum is known to be associated with visceral leishmaniasis in Iran and canids are natural reservoirs. Control of disease in dogs appears to be one of the most effective approaches for interrupting the domestic cycle of the disease. In search for successful vaccine strategies, we evaluated the cysteine proteinases (CPs) type I and II using a heterologous prime–boost regime for vaccination against experimental visceral leishmaniasis in dogs. Following vaccination and challenge, dogs were followed for 12 months. Ten dogs vaccinated by prime/boost with DNA/recombinant CPs (in combination with CpG ODN and Montanide 720) remained free of infection in their bone morrow. In contrast, three out of four dogs in the control groups had infection in their bone marrow. The peripheral lymphocytes from protected animals had generally higher proliferation responses to F/T antigen, recombinant CPA (rCPA) and recombinant CPB (rCPB) than controls. During post-challenge period, the difference in stimulation index is significant (p < 0.05) on months 11 and 12 to F/T antigens, all months for rCPA and 5, 7, 9, 11 and 12 months for rCPB. Analysis of cytokine mRNA level suggested that vaccinated dogs had elevated IFN-γ mRNA in peripheral blood mononuclear cells (PBMC), whereas there was a consistent increase in the level of IL-10 in the control groups and some vaccinated dogs. The level of total IgG and IgG2, but not IgG1, to rCPA and rCPB was significantly higher in the vaccinated group (p < 0.05) than the control groups. We also showed that with the exception of one dog, all dogs in the vaccinated group in comparison to control dogs had strong DTH responses. We propose that the combination of DNA and recombinant protein vaccination using CPs could be instrumental to control (VL) in dogs." @default.
• W2020508488 created "2016-06-24" @default.
• W2020508488 creator A5004798863 @default.
• W2020508488 creator A5006191798 @default.
• W2020508488 creator A5015534998 @default.
• W2020508488 creator A5022582192 @default.
• W2020508488 creator A5027554578 @default.
• W2020508488 creator A5029184531 @default.
• W2020508488 creator A5045644761 @default.
• W2020508488 creator A5046647287 @default.
• W2020508488 creator A5060663651 @default.
• W2020508488 creator A5063010036 @default.
• W2020508488 creator A5078905826 @default.
• W2020508488 date "2005-05-25" @default.
• W2020508488 modified "2023-09-30" @default.
• W2020508488 title "Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of ." @default.
• W2020508488 cites W1481358372 @default.
• W2020508488 cites W151941690 @default.
• W2020508488 cites W1644150848 @default.
• W2020508488 cites W1882062365 @default.
• W2020508488 cites W1981343187 @default.
• W2020508488 cites W1995543014 @default.
• W2020508488 cites W2021593948 @default.
• W2020508488 cites W2021617407 @default.
• W2020508488 cites W2027969728 @default.
• W2020508488 cites W2033431194 @default.
• W2020508488 cites W2043813518 @default.
• W2020508488 cites W2043994562 @default.
• W2020508488 cites W2051422606 @default.
• W2020508488 cites W2051703773 @default.
• W2020508488 cites W2053256900 @default.
• W2020508488 cites W2053949022 @default.
• W2020508488 cites W2054939920 @default.
• W2020508488 cites W2076375813 @default.
• W2020508488 cites W2078886897 @default.
• W2020508488 cites W2080853210 @default.
• W2020508488 cites W2087299685 @default.
• W2020508488 cites W2092205546 @default.
• W2020508488 cites W2095331802 @default.
• W2020508488 cites W2095523168 @default.
• W2020508488 cites W2109966400 @default.
• W2020508488 cites W2112562740 @default.
• W2020508488 cites W2112904488 @default.
• W2020508488 cites W2117451755 @default.
• W2020508488 cites W2135921009 @default.
• W2020508488 cites W2148589496 @default.
• W2020508488 cites W2155527742 @default.
• W2020508488 cites W2159767511 @default.
• W2020508488 cites W2162160321 @default.
• W2020508488 cites W2321171968 @default.
• W2020508488 cites W2398288084 @default.
• W2020508488 cites W2415942832 @default.
• W2020508488 doi "https://doi.org/10.1016/j.vaccine.2005.02.009" @default.
• W2020508488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15882533" @default.
• W2020508488 hasPublicationYear "2005" @default.
• W2020508488 type Work @default.
• W2020508488 sameAs 2020508488 @default.
• W2020508488 citedByCount "131" @default.
• W2020508488 countsByYear W20205084882012 @default.
• W2020508488 countsByYear W20205084882013 @default.
• W2020508488 countsByYear W20205084882014 @default.
• W2020508488 countsByYear W20205084882015 @default.
• W2020508488 countsByYear W20205084882016 @default.
• W2020508488 countsByYear W20205084882017 @default.
• W2020508488 countsByYear W20205084882018 @default.
• W2020508488 countsByYear W20205084882019 @default.
• W2020508488 countsByYear W20205084882020 @default.
• W2020508488 countsByYear W20205084882021 @default.
• W2020508488 countsByYear W20205084882022 @default.
• W2020508488 countsByYear W20205084882023 @default.
• W2020508488 crossrefType "journal-article" @default.
• W2020508488 hasAuthorship W2020508488A5004798863 @default.
• W2020508488 hasAuthorship W2020508488A5006191798 @default.
• W2020508488 hasAuthorship W2020508488A5015534998 @default.
• W2020508488 hasAuthorship W2020508488A5022582192 @default.
• W2020508488 hasAuthorship W2020508488A5027554578 @default.
• W2020508488 hasAuthorship W2020508488A5029184531 @default.
• W2020508488 hasAuthorship W2020508488A5045644761 @default.
• W2020508488 hasAuthorship W2020508488A5046647287 @default.
• W2020508488 hasAuthorship W2020508488A5060663651 @default.
• W2020508488 hasAuthorship W2020508488A5063010036 @default.
• W2020508488 hasAuthorship W2020508488A5078905826 @default.
• W2020508488 hasConcept C104317684 @default.
• W2020508488 hasConcept C137061746 @default.
• W2020508488 hasConcept C147483822 @default.
• W2020508488 hasConcept C159047783 @default.
• W2020508488 hasConcept C167508917 @default.
• W2020508488 hasConcept C202751555 @default.
• W2020508488 hasConcept C203014093 @default.
• W2020508488 hasConcept C22070199 @default.
• W2020508488 hasConcept C2776555147 @default.
• W2020508488 hasConcept C2777625542 @default.
• W2020508488 hasConcept C2778689377 @default.
• W2020508488 hasConcept C2780801004 @default.
• W2020508488 hasConcept C2781257258 @default.
• W2020508488 hasConcept C40767141 @default.
• W2020508488 hasConcept C55493867 @default.
• W2020508488 hasConcept C71924100 @default.

• next